National Action Plan for the Elimination of MDR TB
|
Other
|
CDC
|
NIAID, CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NICHD, NIDA
|
Federal agencies involved in the National Action Plan for the Elimination of Multidrug-Resistant Tuberculosis (MDR-TB) coordinate reporting across agencies. Annual reporting and regular updates on opportunities for cross-agency collaboration and information sharing are provided.
|
National Advisory Board for Medical Rehabilitation Research
|
Committee, Work group, Advisory group, or Task Force
|
ACL, CDC
|
NICHD, NHLBI, NIA, NIAMS, NIDCD, NINDS, OD/DPCPSI
|
The National Advisory Board for Medical Rehabilitation Research (NABMRR) is a Federal Advisory Committee that is composed of researchers, clinicians, and members of the public that advise the Directors of the National Center for Medical Rehabilitation Research, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institutes of Health on issues related to research in medical rehabilitation. The Board includes Ex Officio members from various Federal Departments and Agencies to aid in the coordination of Federal programs, activities, projects, and plans for the same with respect to the conduct of research related to rehabilitation of individuals with disabilities. In 2015, the Board provided advice and consultation on: the development of a NIH Rehabilitation Research Plan, the review and marketing of a Medical Rehabilitation Research Infrastructure Network, the structure and funding of training opportunities for rehabilitation scientists, and concept approval for programs planned by the NCMRR.
|
National Amyotrophic Lateral Sclerosis (ALS) Registry
|
Resource Development
|
ATSDR, CDC
|
NINDS
|
The National ALS Registry is a congressionally mandated registry for persons in the US with ALS. It is the only population-based registry in the US that collects information to help scientists learn more about who gets ALS and its causes.
|
National Cancer Control Strategy
|
Meeting/ Workshop
|
CDC
|
NCI
|
The National Cancer Control Strategy is a National Cancer Institute (NCI) funded study through the National Academies of Sciences, Engineering, and Medicine, which examines cancer control efforts in the United States. This study is expected to produce a report in 2018, which will recommend a national strategy to reduce the incidence, morbidity, and mortality from cancer and to improve quality of life for cancer survivors.
|
National Clinical Care commission
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIDDK
|
The National Clinical Care Commission (NCCC) evaluates and provides recommendations on the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from insulin-related issues and represent a significant disease burden in the United States, including complications due to such diseases.
The Assistant Secretary for Health (ASH) provides guidance and oversight for the Commission’s function and activities. The Office of Disease Prevention and Health Promotion (ODPHP) will provide management and support services for the Commission’s activities.
The NCCC will conduct activities until October 2021.
|
National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI
|
Scientific Steering Committees (SSCs) are composed of leading cancer experts and advocates from outside the Institute as well as the National Cancer Institute (NCI) senior investigators who meet regularly to: (1) increase the transparency and openness of the trial design and prioritization process; (2) enhance patient advocate and community oncologist involvement in clinical trial design and prioritization; (3) convene Clinical Trial Planning Meetings to identify critical questions, unmet needs, and prioritize key strategies.
|
National Coalition for Oversite of Assisted Reproductive Technologies (NCOART)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD
|
The National Coalition for Oversight of Assisted Reproductive Technologies (NCOART) has become a successful forum for discussion of issues by organizations involved in the assisted reproductive technologies (ART) in the United States.
|
National Collaborative on Childhood Obesity Research (NCCOR)
|
Research Initiative
|
CDC
|
NICHD, NCI, NHLBI, NIDDK, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP
|
The mission of the National Collaborative on Childhood Obesity Research is to improve the efficiency, effectiveness, and application of childhood obesity research, and to halt -- and reverse -- childhood obesity through enhanced coordination and collaboration.
|
National Collaborative on Childhood Obesity Research (NCCOR)
|
Research Initiative
|
CDC
|
OD/DPCPSI/ODP, NCI, NHLBI, NICHD, NIDDK, OD/DPCPSI/OBSSR
|
Launched in 2009, the National Collaborative on Childhood Obesity Research (NCCOR) brings together four of the nation’s leading research funders — the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Robert Wood Johnson Foundation (RWJF), and the U.S. Department of Agriculture (USDA) — to accelerate progress in reducing childhood obesity in America. These leading national organizations: work in tandem to manage projects and reach common goals; coordinate funding to make the most of available resources; and share insights and expertise to strengthen research. NCCOR focuses on efforts that have the potential to benefit children, teens, and their families, and the communities in which they live.
|
National Coordinated Child Safety Initiative Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, HRSA
|
NICHD
|
The Child Safety Network is supported by the National Coordinated Child Safety Initiative Steering Committee, which works to create new synergy among public and private stakeholders and to support the activities of the Child Safety Collaborative Innovation and Improvement Network (CoIIN) strategy teams. The Steering Committee will provide advice to the Child Safety CoIIN and help communicate the lessons and accomplishments of the Child Safety CoIIN to a broad national audience that will include public health professionals, policymakers, funders, and families.
|